142 related articles for article (PubMed ID: 21404578)
1. [Matrix metalloproteinase (MMP)-3 is not effective for evaluating hemophilic arthropathy].
Ogata K; Amano K; Kato H; Fukutake K
Rinsho Byori; 2011 Jan; 59(1):37-41. PubMed ID: 21404578
[TBL] [Abstract][Full Text] [Related]
2. Association of baseline levels of urinary glucosyl-galactosyl-pyridinoline and type II collagen C-telopeptide with progression of joint destruction in patients with early rheumatoid arthritis.
Garnero P; Gineyts E; Christgau S; Finck B; Delmas PD
Arthritis Rheum; 2002 Jan; 46(1):21-30. PubMed ID: 11817593
[TBL] [Abstract][Full Text] [Related]
3. The combination of the biomarkers urinary C-terminal telopeptide of type II collagen, serum cartilage oligomeric matrix protein, and serum chondroitin sulfate 846 reflects cartilage damage in hemophilic arthropathy.
Jansen NW; Roosendaal G; Lundin B; Heijnen L; Mauser-Bunschoten E; Bijlsma JW; Theobald M; Lafeber FP
Arthritis Rheum; 2009 Jan; 60(1):290-8. PubMed ID: 19116938
[TBL] [Abstract][Full Text] [Related]
4. Effect of matrix metalloproteinase-3 functional SNP on serum matrix metalloproteinase-3 level and outcome measures in Japanese RA patients.
Tsukahara S; Shinozaki M; Ikari K; Mochizuki T; Inoue E; Tomatsu T; Hara M; Yamanaka H; Kamatani N; Momohara S
Rheumatology (Oxford); 2008 Jan; 47(1):41-4. PubMed ID: 18077489
[TBL] [Abstract][Full Text] [Related]
5. [Role of matrix metalloproteinase-3 in joint destruction in rheumatoid arthritis].
Sugiyama E
Clin Calcium; 2007 Apr; 17(4):528-34. PubMed ID: 17404481
[TBL] [Abstract][Full Text] [Related]
6. [Usefulness of serum matrix metalloproteinase-3(MMP-3) level in the diagnosis of rheumatoid arthritis].
Yamanaka H
Nihon Rinsho; 2002 Dec; 60(12):2325-30. PubMed ID: 12510357
[TBL] [Abstract][Full Text] [Related]
7. High serum cartilage oligomeric matrix protein determines the subset of patients with early-stage rheumatoid arthritis with high serum C-reactive protein, matrix metalloproteinase-3, and MRI-proven bone erosion.
Fujikawa K; Kawakami A; Tamai M; Uetani M; Takao S; Arima K; Iwamoto N; Aramaki T; Kawashiri S; Ichinose K; Kamachi M; Nakamura H; Origuchi T; Ida H; Aoyagi K; Eguchi K
J Rheumatol; 2009 Jun; 36(6):1126-9. PubMed ID: 19447929
[TBL] [Abstract][Full Text] [Related]
8. Increased levels of serum matrix metalloproteinase-3 in haemodialysis patients with dialysis-related amyloidosis.
Naganuma T; Sugimura K; Uchida J; Tashiro K; Yoshimura R; Takemoto Y; Nakatani T
Nephrology (Carlton); 2008 Apr; 13(2):104-8. PubMed ID: 18275497
[TBL] [Abstract][Full Text] [Related]
9. [Correlations between serum matrix metalloproteinase (MMP-1, MMP-3, MMP-9, MMP-13) concentrations and markers of disease activity in early rheumatoid arthritis].
Fiedorczyk M; Klimiuk PA; Sierakowski S; Domysławska I; Chwiećko J
Przegl Lek; 2005; 62(12):1321-4. PubMed ID: 16786739
[TBL] [Abstract][Full Text] [Related]
10. Matrix metalloproteinases MMP-3 and MMP-1 levels in sera and synovial fluids in patients with rheumatoid arthritis and osteoarthritis.
Mahmoud RK; El-Ansary AK; El-Eishi HH; Kamal HM; El-Saeed NH
Ital J Biochem; 2005; 54(3-4):248-57. PubMed ID: 16688934
[TBL] [Abstract][Full Text] [Related]
11. The effects of interferon-beta treatment of synovial inflammation and expression of metalloproteinases in patients with rheumatoid arthritis.
Smeets TJ; Dayer JM; Kraan MC; Versendaal J; Chicheportiche R; Breedveld FC; Tak PP
Arthritis Rheum; 2000 Feb; 43(2):270-4. PubMed ID: 10693865
[TBL] [Abstract][Full Text] [Related]
12. Effect of repeated infliximab therapy on serum matrix metalloproteinases and tissue inhibitors of metalloproteinases in patients with rheumatoid arthritis.
Klimiuk PA; Sierakowski S; Domyslawska I; Chwiecko J
J Rheumatol; 2004 Feb; 31(2):238-42. PubMed ID: 14760791
[TBL] [Abstract][Full Text] [Related]
13. Serum matrix metalloproteinase 3 levels during treatment with sulfasalazine or combination of methotrexate and sulfasalazine in patients with early rheumatoid arthritis.
Posthumus MD; Limburg PC; Westra J; van Leeuwen MA; van Rijswijk MH
J Rheumatol; 2002 May; 29(5):883-9. PubMed ID: 12022344
[TBL] [Abstract][Full Text] [Related]
14. Changes in the concentration of plasma matrix metalloproteinases (MMPs) and tissue inhibitor of metalloproteinases-1 (TIMP-1) after total joint replacement in patients with arthritis.
Omura K; Takahashi M; Omura T; Miyamoto S; Kushida K; Sano Y; Miura M; Nagano A
Clin Rheumatol; 2002 Nov; 21(6):488-92. PubMed ID: 12447632
[TBL] [Abstract][Full Text] [Related]
15. Local expression of the serum amyloid A and formyl peptide receptor-like 1 genes in synovial tissue is associated with matrix metalloproteinase production in patients with inflammatory arthritis.
O'Hara R; Murphy EP; Whitehead AS; FitzGerald O; Bresnihan B
Arthritis Rheum; 2004 Jun; 50(6):1788-99. PubMed ID: 15188355
[TBL] [Abstract][Full Text] [Related]
16. [Stromelysin-1 (MMP-3) level in the sera from patients with rheumatoid arthritis and other connective tissue diseases--clinical significances in early onset rheumatoid arthritis].
Shingu M; Obata K; Ezaki I; Tomari K; Fujikawa Y; Wada T; Nonaka S; Suenaga Y; Iwata K; Nobunaga M
Ryumachi; 1995 Feb; 35(1):15-24. PubMed ID: 7732485
[TBL] [Abstract][Full Text] [Related]
17. Matrix metalloproteinase-3 serum levels are correlated with disease activity and predict clinical response in rheumatoid arthritis.
Ribbens C; Andre B; Jaspar JM; Kaye O; Kaiser MJ; De Groote D; Malaise MG
J Rheumatol; 2000 Apr; 27(4):888-93. PubMed ID: 10782811
[TBL] [Abstract][Full Text] [Related]
18. Altered collagen turnover in factor VIII-deficient rats with hemophilic arthropathy identifies potential novel serological biomarkers in hemophilia.
Manon-Jensen T; Karsdal MA; Nielsen LN; Kjelgaard-Hansen M; Vandahl B; Olsen EH; Enoksson M; Roepstorff K
J Thromb Haemost; 2016 Dec; 14(12):2419-2429. PubMed ID: 27681457
[TBL] [Abstract][Full Text] [Related]
19. Serum levels of hyaluronan, antigenic keratan sulfate, matrix metalloproteinase 3, and tissue inhibitor of metalloproteinases 1 change predictably in rheumatoid arthritis patients who have begun activity after a night of bed rest.
Manicourt DH; Poilvache P; Nzeusseu A; van Egeren A; Devogelaer JP; Lenz ME; Thonar EJ
Arthritis Rheum; 1999 Sep; 42(9):1861-9. PubMed ID: 10513800
[TBL] [Abstract][Full Text] [Related]
20. Serum Sclerostin Level and Bone Mineral Density in Pediatric Hemophilic Arthropathy.
El-Mikkawy DME; Elbadawy MA; Abd El-Ghany SM; Samaha D
Indian J Pediatr; 2019 Jun; 86(6):515-519. PubMed ID: 30671760
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
